Drug intelligence / Profile preview

UV-inactivated reovirus

Development stage
Preclinical
Lead developer
Oncolytics Biotech
Modality
Oncolytic Viruses → Oncolytic Therapeutics
Administration
Intravenous, Ex Vivo (as Laboratory Immunomodulator For Cell-based Studies)
01

Overview

UV-inactivated reovirus refers to reovirus particles that have been rendered non-infectious by exposure to ultraviolet (UV) light. This process inactivates the virus, preventing replication, but preserves structural and immunogenic properties. While replication-competent reovirus is known for its oncolytic (cancer cell lytic) properties, UV-inactivated reovirus acts as an immunomodulatory agent. In preclinical studies, UV-inactivated reovirus has been shown to function as an adjuvant, enhancing activation of dendritic cells and the priming of tumor-specific cytotoxic T lymphocytes. It can also boost antibody-dependent cellular cytotoxicity (ADCC) when combined with agents like anti-CD20 antibodies. Thus, UV-inactivated reovirus is explored primarily as a vaccine adjuvant or immunostimulant, rather than a direct oncolytic therapy[1][2].

Other names
ultraviolet-inactivated reovirusnon-replicating reovirus

Beyond the preview

Go deeper on UV-inactivated reovirus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UV-inactivated reovirus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call